Also trades as: VANIW (OTC) · $vol 0M
VANI NASDAQ
Vivani Medical, Inc.
1W: -0.8%
1M: -13.4%
3M: -5.4%
YTD: -3.1%
1Y: -14.6%
3Y: +23.0%
5Y: -87.8%
$1.23
+0.01 (+0.82%)
Weekly Expected Move ±7.5%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-02-08
Earliest Filing
2025-10-28
Latest Filing
target: 3
partner: 2
Counterparties (Filed by VANI)
5 relationshipsCompanies named in VANI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ThinkEquity LLC | — | partner | Placement agent for the registered direct offering of common stock. | 2025-10-28 | View |
| Cortigent, Inc. | — | partner | Wholly owned subsidiary receiving transition funding and services from parent company | 2023-03-21 | View |
| Nano Precision Medical, Inc. | — | target | Target company in the business combination merger. | 2022-09-02 | View |
| Nano Precision Medical, Inc. | — | target | Target company in a proposed merger agreement with the registrant. | 2022-06-21 | View |
| Nano Precision Medical, Inc. | — | target | Target company in a merger agreement to be acquired by Second Sight Medical Products, Inc. | 2022-02-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-16 | Regulation FD | View | |
| 2026-08-17 | Regulation FD; Exhibits | View | |
| 2026-08-13 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-08-06 | Regulation FD; Exhibits | View | |
| 2026-07-16 | Regulation FD; Exhibits | View | |
| 2026-07-07 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-06-30 | Officer/Director Change; Shareholder Vote; Other Events; Exhibits | View | |
| 2026-06-04 | Regulation FD; Exhibits | View | |
| 2026-05-13 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-01-27 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-11-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-10-03 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-17 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-09-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-13 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere | Agreement | View |
| 2025-08-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-06-25 | Submission of Matters to a Vote of Security Holders | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR